Circulating Prostate-Specific Antigen/CD14-Double-Positive Cells: a Biomarker Indicating Low Risk for Hematogeneous Metastasis of Prostate Cancer
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.